Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.

Slides:



Advertisements
Similar presentations
RRT and Intoxications Timothy E Bunchman. Case Study-1 17 y/o female with poly pharmacy overdose including risperidone, stratttera and long acting Lithium.
Advertisements

Pediatric CRRT Terms and Nomenclature Timothy E. Bunchman.
Renal Replacement Therapy for Acute Renal Failure Timothy E. Bunchman Professor Pediatrics.
Separation Technology in Dialysis
Maxvold Nutrition in PCRRT Norma J Maxvold Pediatric Critical Care.
Norma J Maxvold Pediatric Critical Care
Renal Replacement Therapy
Renal Replacement Therapy Options for Children
Pediatric CRRT: Terminology and Physiology
Definition Continuous Renal Replacement Therapy (CRRT)
CVVH vs CVVHD Does it Matter?
Not necessarily a recipe
So how do I dose this drug “X” Timothy E Bunchman
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
NON-TRADITIONAL RENAL REPLACEMENT THERAPY Hafez Bazaraa.
CRRT solutions Benan Bayrakci, 2014.
Case Study in RRT in In Born Error of Metabolism Timothy E. Bunchman Pediatric Nephrology & Transplantation VCU School of Medicine
Dialysis and Replacement Solutions for CRRT
Access n If you don’t have it you might as well go home. n This is the most important aspect of CRRT therapy. n Adequacy. n Filter life. n Increased blood.
Troubleshooting Issues in CVVH Timothy L. Kudelka RN, BSN Pediatric Dialysis Program C.S. Mott Children’s Hospital University of Michigan.
RENAL REPLACEMENT THERAPY
Pediatric CRRT The Prescription: Rates, Dose, Fluids
Terminology and Common Issues in Pediatric CRRT John Gardner RN, BSN Nurse Manager Pediatric Nephrology & Transplant DeVos Children’s Hospital Grand Rapids.
Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his.
Pediatric CRRT: The Prescription
Dialysis and Replacement Solutions for Pediatric CRRT
Pediatric CRRT: The Prescription Stuart L. Goldstein, MD Associate Professor of Pediatrics Baylor College of Medicine.
What form of anticoagulation is the “best” Or why is Citrate better then Heparin or Prostacyclin.
The Prospective Pediatric CRRT (ppCRRT) Registry Stuart L. Goldstein, MD Principal Investigator and Founder Timothy E Bunchman Helen DeVos Children’s Hospital.
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
PCRRT PRESCRIPTIONS in ARF Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
Is There a Rationale To Use CRRT For Treating Sepsis? James D. Fortenberry MD, FCCM, FAAP Pediatrician in Chief Children’s Healthcare of Atlanta Professor.
Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology
DIALYSIS SOLUTIONS INC.
Sustained Low Efficiency Dialysis
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
Renal Replacement Therapy for Intoxications Timothy E. Bunchman Pediatric Nephrology & Transplantation DeVos Children’s Hospital Grand Rapids, MI (thanks.
University of Pittsburgh
Brophy University of Iowa Pediatric CRRT Anticoagulation Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital PCRRT.
Citrate Anticoagulation
Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.
Renal Replacement Therapy
ANTICOAGULATION PCRRT 2008 Orlando Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital.
Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan.
PCRRT Multi-Center Registry Data Effective April 1, 2002 Multi-Center Pediatric CRRT Registry Stuart L. Goldstein, MD Assistant Professor of Pediatrics.
Vascular Access in CRRT Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Dosing of Anti-Fungal agents on CRRT Timothy E. Bunchman Professor and Director Pediatric Nephrology & Transplantation Children’s Hospital of Richmond.
PCRRT Tûr'mə-nŏl'ə-jē Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Cytokine and Soluble Fas Ligand Response in Children with Septic Acute Renal Failure (ARF) on CVVH Paden ML, Fortenberry JD, Rigby MR, Trexler AM, Heard.
Prise en charge de l'IRA au cours du sepsis " Quelle place pour l’hémofiltration continue ? " Bertrand Souweine Clermont-Ferrand.
Convection (CVVH) is Better! Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Rajeev Annigeri. Apollo Hospitals, Chennai.
CRRT TERMINOLOGY Stefano Picca, MD
CONTINUOUS RENAL REPLACEMENT THERAPY
CRRT Fundamentals Pre- and Post- Test
When fluids go wrong: CRRT in fluid overload
Access for Pediatric CRRT
Case – Peritoneal Dialysis - PD
Improving outcomes in AKI and CRRT: Does Quality matter?
Hemodialysis in 20 kg Patient with AKI and Sepsis
Devices use for Neonatal AKI
Prescriptions in CRRT Timothy E Bunchman MD Professor & Director
CRRT Fundamentals Pre- and Post- Test Answers
Case studies in RRT ( Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Pharmacokinetics & Drug Dosing
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Pediatric CRRT Terminology
Basics of CRRT: Terminology
CRRT dialysis circuit using regional citrate anticoagulation with the Gambro Prisma machine. CRRT dialysis circuit using regional citrate anticoagulation.
Presentation transcript:

case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100 mg/dl

What is your prescription Access, size and location BFR if applicable What is your solution (bicarb, lactate, etc) What is your dialysate/convection flow rate Anticoagulation Over what period of time do you remove fluid How do you dose medications and nutrition

CRRT Case Prescription Timothy E Bunchman MD Professor & Director Pediatric Nephrology Timothy.bunchman@vcuhealth.org pedscrrt@gmail.com www.pcrrt.com

Access, size and location and BFR Proper location BFR Access dependent with a beginning rate of ~ 5 mls/kg/min BFR may increase unless risk of osmolar shift

Solutions components Historical solutions were lactate based This will result in plasma lactate levels being detected making the question of sepsis or tissue damage a concern All present commercially made solutions are bicarbonate based Physiologic components of Na, K, Ca (if heparin based), HCO3 as well as phosphorous as needed

Convective Clearance To increase clearance by convection, increase ultrafiltration rate (will require more replacement fluids)

Sieving Coefficients Solute (MW) Convective Coefficient Diffusion Coefficient Urea (60) 1.01 ± 0.05 1.01 ± 0.07 Creatinine (113) 1.00 ± 0.09 1.01 ± 0.06 Uric Acid (168) 1.01 ± 0.04 0.97 ± 0.04* Vancomycin (1448) 0.84 ± 0.10 0.74 ± 0.04** Calcium (protein bound) 0.67 + 0.1 0.61 + 0.07 Cytokines (large) adsorbed minimal clearance *P<0.05 **P<0.01

ppCRRT [Cytokine] % Change: Convection vs. Diffusion TNF-alpha -3.7 + 9.6 3.9 + 9.1 0.08 IL-1 beta -2.8 + 14.8 1.4 + 12.9 0.46 IL-6 32.7 + 102.8 -2.6 + 18.4 0.21 IL-8 -29.1 + 26.0 - 8.3 + 17.2 0.018 IL-10 -44.6 + 29.0 3.1 + 45.0 0.007 IL-18 -13.6 + 17.9 16.9 + 24.7 0.002 PELOD -22 + 34 -6 + 30 0.26

How aggressive do you UF? Net UF is often targeted to ~ 0.5-2 mls/kg/hr but is dependent upon hemodynamics Rule of thumb Take off the fluid at about the same rate as it was required

pH correction upon Epi effect (mic/kg/min) MAP Time

Comparison of Total Amino Acid losses: CVVH vs CVVHD (Maxvold et al, Crit Care Med 2000 Apr;28(4):1161-5 ) NS Amino Acid Losses (g/day/1.73 m2)

Medication dosing If possible make continuous If possible use medications that can be measured (e.g Vancomycin) Knowing Vanco in s~ 1500 Kda and ~ 75% protein bound will add it deciding dosing and frequency on other medications Vaso pressor agents are often small molecular weight and non protein bound so the clearance will be immediate

So my prescription would be IJ triple lumen 12 Fr catheter BFR ~ 150 mls/min Convection clearance at ~ 2-2.5 liters/m2/hr or ~ 40 mls/kg/hr Citrate anticoagulation Net UF initially zero then once stable will target ~ 1-2 mls/kg/hr net UF TPN/enteral nutrition ~ 3 gms/kg/day Meds Vanc and a cephalosporin with vasopressors adjusted for MAP

Comparison of RRT modalities Modality CRRT SLED HD (standard or HF) PD CFPD BFR 3-5 mls/kg/min access dependent 10-20 mls/kg/pass 20-40 mls/kg/pass Dialysis Flow Rate 0-4 liters/hr 6 liters /hr 30-50 liters/hr 0.5-2 liters/hr Convective Flow Rate Systemic Anticoagulation Heparin or citrate Heparin or none none Thermic control Yes yes partial Ultrafiltration control Solutions Industry made On Line production Drug clearance Continuous Intermittent Nutritional clearance Hemodynamic stability (1 best; 4 least) 1 4 5 3 2 Solute clearance